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Abstract: Specific protein domains known as protein transduction domains (PTDs) can 
permeate cell membranes and deliver proteins or bioactive materials into living cells. 
Various approaches have been applied for improving their transduction efficacy. It is, 
therefore, crucial to clarify the entry mechanisms and to identify the rate-limiting steps. 
Because of technical limitations for imaging PTD behavior on cells with conventional 
fluorescent-dyes, how PTDs enter the cells has been a topic of much debate. Utilizing 
quantum dots (QDs), we recently tracked the behavior of PTD that was derived from HIV-1 
Tat (TatP) in living cells at the single-molecule level with 7-nm special precision. In this 
review article, we initially summarize the controversy on TatP entry mechanisms; 
thereafter, we will focus on our recent findings on single-TatP-QD tracking (SQT), to 
identify the major sequential steps of intracellular delivery in living cells and to discuss 
how SQT can easily provide direct information on TatP entry mechanisms. As a primer for 
SQT study, we also discuss the latest findings on single particle tracking of various 
molecules on the plasma membrane. Finally, we discuss the problems of QDs and the 
challenges for the future in utilizing currently available QD probes for SQT. In conclusion, 
direct identification of the rate-limiting steps of PTD entry with SQT should dramatically 
improve the methods for enhancing transduction efficiency. 
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1. Introduction 
It has been believed that peptides and proteins usually do not penetrate the cell membrane. 
Therefore, to make proteins/peptides function inside the cell, viral vector-mediated gene expression  
or gene transfection are considered as the most reliable approach for expressing functional 
proteins/peptides de novo in cells. An alternative approach that appears to be the safest is to produce 
recombinant proteins exogenously and then to inject them into individual target cells by   
micro-injectors. However, there are several drawbacks to these methods; for example, the efficiency of 
gene introduction by viral vector-mediated methods is not adequate for non-dividing cells. On the 
other hand, owing to the complexity of the procedure, localized injections cannot handle many cells at 
a time. Furthermore, to analyze the function of a gene at the individual level, a large time- and   
labor-consuming effort is required for generating genetically modified organisms, such as mouse, fly, 
or nematodes. Instead of these methods, direct protein transduction and the functioning in cells or 
tissues of a protein transduction domain has received substantial attention recently. This approach 
appears to be excellent with respect to safety because this technique does not alter the host genome in 
comparison to gene expression methods. Moreover, it is expected that researchers will accelerate their 
speed for analyzing the function of proteins on both cellular and tissue levels; thus, protein 
transduction is one of the most promising technologies in the post-genomic era but research on this 
method is not yet complete.  
Because a cell is isolated from the extracellular environment by the lipid bilayer plasma membrane, 
it was thought to be difficult to directly introduce proteins into the cells from outside. However, in 
1988, Frankel and Pabo [1] and Green and Lowenstein [2] independently demonstrated that 
extracellular human immunodeficiency virus I type (HIV-1) trans-activator of transcription protein 
(Tat) crosses the plasma cell membranes and enters living cells. Thereafter, proteins with direct protein 
transduction ability were found in a wide variety of species (Table 1), such as antennapedia, a 
Drosophila homeodomain transcription factor [3], and VP22, a Herpes simplex virus 1 structural 
protein [4]. Subsequently, a more detailed analysis of the proteins led to the identification of a 10 to 20 
amino acid sequence that has been designated as the Protein Transduction Domain (PTD). This 
segment has been found to be essential for transducing the proteins [5–10]. The group of amino acids 
that are basic in nature, including Arg and Lys, is critical in the PTD, to allow the proteins to cross the 
cell membranes. Several studies have reported that gene engineering or chemical modification, which 
can fuse or conjugate the target protein to a PTD, show protein transduction properties in vivo and  
in vitro [5,11–15]. These results accelerate the critical research questions to be answered for utilizing 
the PTD for transducing the target protein. They have also been shown to mediate the efficient intracellular 
accumulation of various biologically active substances such as antisense oligonucleotides [16], 
plasmids [8,17,18], peptide nucleic acids [19,20], short interfering RNAs (siRNAs) [21], radioisotopes [22], 
iron nanoparticles [23], and liposomes [24]. They can also effectively suppress the functions of 
signaling molecules [25,26] or transcription factors [27] by introducing synthetic peptides that can 
inhibit enzymatic activity. Moreover, it has been speculated that they open up a new avenue for 
introducing various molecules, such as fluorophores, for labeling intracellular molecules [28,29], and 
affinity labeling agents to analyze the intracellular-molecular interactions in living cells.  
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Table 1. Amino acid sequence of protein transduction domains. 
Name Species  Sequence 
Tat (49-57)  HIV-1  GRKKRRQRRRPPQ 
Antennapedia Drosophila  RQIKIWFQNRRMKWKK 
VP22 HSV-1  DAATATRGRSAASRPTERPRAPARSASRPRRPVD 
In summary, protein transduction methods have the following advantages: (i) transduction 
procedures are easy, and the effects can be observed in a short period; (ii) not only the protein but also 
various macromolecules can be introduced into the cells; (iii) they are very safe, as they do not alter 
the host genome; and (iv) bioactive macromolecules can be introduced into tissues by simple 
intravenous or intraperitoneal injection. Therefore, protein transduction methods are expected to be an 
innovative technology for improving the efficacy of delivering bioactive molecules as well as quickly 
analyzing the protein function both in vitro and in vivo.  
However, protein transduction technologies have some important limitations [30,31]. For example, 
transduction efficiency is greatly influenced by the character of the target protein and, in many cases, 
sufficient efficacies were rarely achieved even with in vivo experiments [31]. To overcome these 
problems, extensive research is currently being focused on improving the transduction efficacy. In 
contrast, the pathway by which these peptides enter the cells has been the subject of substantial 
controversy over the last decade. This controversy was partly due to the lack of state-of-the-art 
techniques for the direct visualization of the behavior of PTDs; thus, the initial events at the cell 
surface have been predicted based only on biological activities (e.g., the activity of the reporter genes) 
or the amount of PTDs or PTD-fused protein that is inside the cells after 1 h of exposure. As a result, 
improving the efficacy, such as identifying the PTD derivative peptides that have a higher transduction 
efficiency, still depends on the biological activities measured by black boxing the transduction machinery. 
In the present review, we initially focus on the outcome of using quantum dot (QD) labeled   
HIV-1-Tat PTD (TatP), which is the most intensely studied yet the least understood peptide in protein 
transduction. We focus also on the visualization of single particles and their entry mechanisms. In this 
regard, we share our recent findings using single QD imaging of TatP in living cells, by virtue of 
replicating this method, and using QD probes to explore novel findings in many other biological events. 
Therefore, we first discuss the currently proposed models of protein transduction that focus mainly on 
the TatP. Then, as a primer for a single particle study, we discuss the latest findings that were obtained 
by single particle tracking of various molecules on the plasma membrane [32]. Thereafter, we will 
introduce our findings, and finally, we will discuss the problems of using currently available QD 
probes for live cell imaging. 
2. Controversies in Protein Transduction Mechanisms and the Ambiguities that Arise from 
Conventional Dyes 
PTDs have been shown to be structurally diverse and highly variable in character. Their common 
feature is the existence of basic amino acid residues (Arg and Lys) in higher density [31]. In general, 
the presence of basic amino acids and a high charge at physiological pH are thought to be the most 
striking features of PTDs; however, there are some exceptions, suggesting that the transduction Sensors 2012, 12  552 
 
 
machinery may not be so simple. Various hypotheses have been proposed about what makes it possible 
for these peptides to translocate across biological membranes. A diverse set of experiments suggests 
the possibility of more than one contributing mechanism of transduction [31,33–45].  
Among the TatP entry mechanisms proposed is that TatP may be able to spontaneously translocate 
across the cell membrane, as suggested by several experiments that indicate non-endocytosis mediated 
a non-energy-dependent process for their entry [33]. The TatP is a strongly charged, highly hydrophilic 
peptide; therefore, it is difficult to understand how this peptide can cross the hydrophobic barrier 
imposed by the cell membrane. It has been shown experimentally that the secondary structure of TatP 
does not influence its transduction capability because the L-and D-amino-acid sequence, as well as the 
reverse TatP sequence, can translocate through the membrane [46,47]. Substitution of any of the TatP 
cationic residues with neutral Ala decreases the activity, while substitution of neutral residues has no 
effect [47]. These observations indicate the importance of electrostatic interactions between cationic 
TatP and anionic phospholipid membranes [34,35,48]. The TatP is shown to interact strongly with 
localized negative charges in both anionic and neutral zwitterionic lipids, such as 1,2-dioleoyl-sn-
glycero-3-phosphocholine and 1,2-dioleoyl-sn-glycero-3-[phospho-l-serine]; however, comparatively, 
a higher concentration of TatP is required for their translocation [34]. Crystallographic study showed 
that aqueous solutions of simple phospholipids and TatP undergo a phase transition from a lipid 
bilayer to a Pn3m double-diamond phase, where the lipid molecules have induced negative Gaussian 
curvatures and surround 6-nm water pores [34,49]. The transduction activity of TatP correlates with its 
ability to induce negative Gaussian curvature. Molecular dynamics simulations also suggest that strong 
interactions between the TatP and the phosphate groups on both sides of the lipid bilayer occur. Also 
present are the insertion of charged side chains that nucleate the formation of a transient pore,   
followed by the translocation of the Tat peptides by diffusing on the pore surface [36]. Similar to the 
crystallographic study in [34], a simulation study also suggests that a relatively high concentration of 
peptides per lipid (P/L = ~1/8) is required for their plasma membrane translocation. Collectively, these 
finding challenge the hypothesis that the transduction activity of TatP can be explained solely by its 
ability to perform direct membrane translocation.  
According to another mechanism for the TatP entry, cell surface heparin sulfate (HS) proteoglycans 
(HSPGs) have been shown to play a certain role in the transduction of the peptide [37–40]. HSPGs are 
expressed in almost all of the cell types [50]. The relationship between TatP/TatP-fusion proteins and 
HSPGs are shown in the following experiments: First, treatment of the cells is performed with 
heparinase III, which removes the HS and significantly suppresses the efficacy of TatP transduction [51]. 
Second, when the heparin is added, a soluble analogue of HS glycosaminoglycans (GAGs) inhibits 
TatP transduction [52]. In vitro experiments with sodium azide, an inhibitor for the production of ATP 
and the endocytotic pathway, have been shown to suppress the TatP/TatP-fusion protein transduction, 
suggesting that TatP transduction may be induced through endocytotic pathways [41,42]. Furthermore, the 
protein transduction was significantly inhibited by energy depletion in cells at low temperatures [43,44]. In 
addition, the initial study suggested that TatP enters the cells with a non-energy dependent entry; 
however, this result has now been shown to be an experimental artifact caused by the cell fixation 
process [53]. Additionally, it has been shown that the peptide is incorporated into the acidic 
compartment of the cells and the TatP transduction efficacy is strongly reduced by the inhibition of 
endosomal acidification [41].  Sensors 2012, 12  553 
 
 
Wadia and Dowdy invented very sophisticated systems, using a transducible TatP-Cre recombinase 
and a loxP-stop-loxP reporter assay on live cells [45]. These investigators showed that after an initial 
ionic cell-surface interaction, TatP-fusion proteins are rapidly internalized by lipid raft-dependent 
macropinocytosis. They reported that transduction was independent of caveolar- and clathrin-mediated 
endocytosis and phagocytosis. On the other hand, Richard et al. [44] and Fittipaldi et al. [54] reported 
clathrin- and caveolin-dependent uptake of TatP, respectively. 
When we summarized the issues about the TatP cell entry mechanisms, we found that several 
debates have ensued for over a decade. These include (i) energy dependent vs. non-energy dependent; 
(ii) receptor-dependent surface binding vs. direct plasma membrane binding and translocation; and  
(iii) clathrin-dependent vs. caveolin-dependent endocytosis or macropinocytosis. 
As mentioned above, the pathway by which these peptides enter cells is still controversial. This 
controversy could result from a lack of cutting edge techniques. Biological assays have shown that 
TatP can enter into the cells at a relatively low concentration (~5 nM) [45]. In live cell imaging 
experiments, photobleaching of GFP- and FITC-labeled TatP has been used to explore the mechanisms 
of TatP entry. The high concentrations (~100 nM to 10 μM) of TatP used in these experiments could 
induce the nonspecific entry of TatP into cells [51]; for example, pinocytosis continuously occurs at 
the cell surface, even without stimulation. Increasing the TatP concentration might accelerate this 
nonspecific entry and prevent the discovery of a truly specific entry pathway. Thus, it is difficult to 
identify specific entry pathways using conventional live cell imaging and photobleaching fluorophores. 
Moreover, the absence of any sophisticated techniques for direct visualization and the initial events at 
the cell surface have only been indirectly predicted based on biological activities (e.g., activity of the 
reporter genes) or the amount of TatP inside the cells after ~1 h of TatP exposure. As a result, 
phosphate groups of plasma membrane lipids or cell-surface receptors, namely CXCR4 [55], integrin 
family members [54,56,57], vascular endothelial growth factor receptors [57], low density lipoprotein 
receptor-related proteins [58], and HSPGs [37–39,44], are still considered potential candidates. Thus, no 
uniform conclusions have been reached, even about the initial TatP cellular surface binding mechanisms. 
3. Single Molecular Tracking (SMT) Methods and Usage of QD Probes 
To examine the behavior of individual molecules, two methods have been applied: (i) the single-particle 
tracking (SPT) method, which uses a probe that is slightly larger than colloidal gold particles [59]; and 
(ii) single fluorescent-molecule tracking (SFMT), which uses fluorophores as probes [60,61]. By early 
1990, owing to technical limitations, SPTs have been utilized for examining the behavior of individual 
molecules; thus, the biomolecules are attached to relatively large surface particles and observed under 
interference contrast microscopy. The SPT is characterized by high time-resolution. However, because 
relatively large particles are used as a probe, it is rather difficult to eliminate the possibility that the 
observed molecular behavior could be influenced by steric hindrance. SFMT was first successful in 
1995 [62], with ~20–50 nm spatial precision, but at that time, it could not detect movement of this 
molecular size. 
Recently, the usage of QDs for visualizing single molecule behavior has dramatically changed this 
field [28,63]. This usage results from the invention of functional colloidal QDs, and the usage of the 
QD largely expands the range of single molecular observations. In addition, the development of many Sensors 2012, 12  554 
 
 
methods for functionalizing the surface make it possible to effectively label a wide variety of 
molecules with QDs [29,64]. Their moderate size (5–50 nm), higher brightness, and strong resistance 
to photobleaching make QDs a favorable compromise between using large beads and small yet poorly 
photostable organic dyes to achieve single molecular imaging analysis in living cells. Additionally, 
multicolor probes can be used due to the size-dependent tunable absorption and emission in the visible 
and near infrared (NIR) regions. As a result, utilizing QDs can open up a new gateway for   
“multi-parametric” single molecular imaging experiments.  
When a specific molecular reaction utilizing an ensemble method is analyzed, information on 
heterogeneous behavior, diversity in reaction, and local heterogeneity is often lost [65]. Biochemical 
reactions are, moreover, hardly synchronized inside of living cells; thus, it is always difficult to 
identify specific reaction steps from the information that is obtained by the assembling methods. The 
SMT is especially suitable for examining biochemical reactions that have spatial and temporal 
heterogeneity inside of living cells. In fact, multiple cellular events can be viewed as single molecular 
events because those cellular responses are triggered by a limited number of molecules. Thus, SMT is 
an extremely important tool to explore biological events, especially the existence of local heterogeneity, 
such as the molecular events of neurotransmitters inside of synaptic clefts and antigen recognition 
between immunological cells [28]. As compared to fluorescence recovery after photobleaching (FRAP), 
SMT is expected to authentically analyze molecular events under physiological conditions because the 
overexpression of labeled molecules is not needed. Overexpression of the molecules usually accompanies 
the risk of increasing the molecular density, which significantly influences the equilibrium of the 
biochemical reactions. Organic dyes and fluorescent proteins are typical fluorophores used to label 
molecules. However, despite their small size and their widespread availability in a variety of colors, 
organic dyes suffer from limitations such as narrow excitation band, small Stokes shift, broad 
ﬂuorescence band, and photobleaching [64]. In contrast, broad absorption bands of QDs provide two 
advantages: (i) freedom to select any excitation wavelength below the band gap energy; and (ii) the 
ability to minimize the background by increasing the Stokes shift. Narrow photoluminescence bands of 
QDs are advantageous for minimizing bleeding during multiplexed imaging. Bright and stable 
photoluminescence of QDs permits durable and sensitive bioimaging even at single-molecule levels. 
Therefore, a much higher signal-to-noise ratio visualization can be achieved compared to organic dyes. 
To this end, QD-molecule labeling allows the observation of fluorescent signals for several orders of 
magnitude longer than fluorescent dyes and proteins, i.e., between several minutes to hours. Enhancing 
fluorescence intensity by using QDs, together with reducing vibration and background light of 
microscopes and noise of cameras, can achieve higher spatial precision; therefore, the motion of the 
molecules can be observed over a long period of time with high positional accuracy.For example, in 
our laboratory, we constructed a device that reduces the vibration of the objective lens and the 
microscope stage, which are the main sources of vibration [32,66–68]. We used a higher quality 
optical filter, which transmits only the fluorescent light from the laser, to minimize the background 
light. Additionally, to obtain bright images with less noise, we use an Electron Multiplying CCD 
(EMCCD) camera with a cooling system for electronic amplification (Figure 1(A,B)). It is possible to 
accurately examine a molecular position by determining the light-centroid of the fluorescent spots by 
fitting the fluorescence intensity into the Gaussian distribution. When the number of photons (n) is 
100,000, the fluorescence wavelength (λ) is 600 nm, and the numerical aperture (NA) is 1.3, the Sensors 2012, 12  555 
 
 
theoretical positional accuracy of the light-centroid with the Gaussian function is d = 0.88 nm (because 
the positional accuracy is inversely proportional to the square root of the number of photons); thus, 
“ﬂuorescence imaging with one-nanometer accuracy” (FIONA) can be achieved [69,70]. In fact, 
because of the non-flatness of the mirror and the lens or dust, the resolution appears to have fallen to  
d = ~1 nm. When we utilize very strong excitation light for visualizing a single QD, the expected 
photons for ~1 nm precision can be obtained in about 5 ms of time resolution. In fact, considering the 
phototoxicity of the cells, we reduce the excitation light intensity to 1/100 and collect data at a video 
rate of (~30 ms). We can conduct single molecule imaging of QDs with positional accuracy of ~6 nm 
(Figure 1(C)) [32,67,71]. In addition, by shifting the objective lens of the confocal laser microscope up 
and down with a piezo controller in a multi-speed apparatus, we obtain a confocal image of nine per 
330 ms, and a single three-dimensional image is created. Then, to obtain the three-dimensional 
position of the QDs, we have developed software that calculates the centroid of the fluorescent spot 
weights, to obtain their intensity and to perform a three-dimensional measurement of the position 
changes over time with ~10 nm spatial precision of the Z-section [67,68]. 
Figure 1. Optical system for single molecular imaging. (A) Photograph; (B) Schematic 
drawing of an optical setup for double imaging. A piezo actuator bound to the objective.  
L, lens; M, mirror; DM, dichroic mirror; HM, half mirror cube. Fluorescent images at two 
different wavelengths of QD (path 1 and path 2); (C) spatial precision of TatP-QDs in 
HeLa. Immobile TatP-QDs were tracked in HeLa. The S.D. of the position of QDs was  
6.9 nm in the x axis and 6.5 nm in the y axis.  
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4. Extracting the Meaning of Single Molecule Analysis of the Cell Membrane 
To extract biological meaning from the trajectory of a molecule, a variety of analytical techniques 
have been developed. A commonly used method for analysis is to calculate the diffusion coefficient as 
a function of time, which can be used to rapidly calculate a form of motion (e.g., diffusive, direction, 
limitation) as well as identify additional parameters (e.g., diffusion coefficients, speed of transportation, 
limit sizes) [72,73]. Analysis of SMT revealed many new findings with respect to mechanisms of 
localization and movement of molecules, especially at the surface of the plasma membranes. However, 
observations of molecules inside the cells are currently limited because currently available conventional 
technology is unable to sufficiently incorporate fluorescent dyes and QDs inside the cells, i.e., 
micro/nanoinjection. For visualizing intracellular molecules, there is currently enthusiasm for both 
specific and non-specific introduction of QDs. Simple techniques such as PTD for intracellular protein 
labeling with QDs will be subject to enthusiastic development in the near future. 
 
Figure 2. A schematic presentation of the membrane-skeleton fence model.  Membrane 
proteins are sticking out into the cytoplasm, and in their cytoplasmic domains, collide with 
the membrane actin skeleton, which causes confinement of these membrane proteins into 
membrane skeletal meshes. When extracellular ligand molecules are added, they are bound 
to a receptor monomer and form oligomers. This action induces a dramatic decrease in the 
diffusion rates of such signaling complexes because of the enhanced effects of corralling or 
binding to the fences, and these signaling complexes are immediately arrested within the 
compartment where the signal was received.  
 
 
 
Because the cell membrane is a liquid environment and consists of phospholipids, with proteins 
present in the lipid bilayer, the membrane normally conducts random diffusion. If there is no specific 
molecular mechanism, then anomalous diffusion, such as uneven diffusion or a stoppage of diffusion, 
should not occur. Using SPT, Kusumi and their colleagues found that transmembrane proteins (e.g., 
transferrin receptor, α2 macroglobulin receptor, cadherins, Band 3, the μ-opioid receptor, CD44)   
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showed abnormal thermal motion in all of the examined cell lines [74–79]. The proteins showed 
abnormal diffusion with suppressed free movements rather than simple Brownian movements. The 
studies revealed the following facts: (i) the actin cytoskeleton binds the entire cytoplasmic surface of 
the plasma membrane and forms the membrane skeleton mesh; and (ii) membrane proteins stick out 
into the cytoplasm, and their cytoplasmic domains collide with the membrane skeleton, which causes 
confinement of these membrane proteins (Figure 2) [74,75,77,79].  
To this end, a receptor molecule moves very rapidly within a compartment for a few seconds or more 
on average, and then hops to an adjacent compartment. Therefore, macroscopic diffusion of receptor 
molecules occurs as a result of a series of steps involving intercompartmental hop diffusion. This model 
of a “membrane skeleton fence” has now been widely accepted. Membrane skeleton-induced diffusion 
barriers appear to be important for maintaining spatial information for signals from the receptor 
molecules. For example, when an extracellular signal is bound to a receptor monomer and it forms 
oligomers, this formation would induce a dramatic decrease in the diffusion rates of such signaling 
complexes because of the enhanced effects of corralling or binding to the pickets and fences, and these 
signaling complexes would immediately be arrested within the compartment when it receives a signal (the 
oligomerization-induced trapping model) (Figure 2) [77,78,80,81]. Such an arrest may be the basis for 
the spatial distribution of a certain receptor after it receives a signal. 
As described above, by using an SMT, it can be easier to reveal the molecular mechanisms that are 
linked to molecular localization and movement on the cell surface. Little by little, however, as we 
discover the mechanisms for cell surface molecular dynamics, it becomes possible to identify or infer 
the mechanisms that cause the dynamics, based on our previous findings.  
 
5. Sharing the Findings of TatP Surface Tracking as an Example of Single Particle Tracking 
Using QDs 
 
Developing a technology for delivering QDs into living cells is the most extensively studied 
research area in recent years; therefore, two different groups of researchers have already examined 
whether QDs conjugated with TatP can transduce QDs into living cells. Ruan et al. reported that  
TatP-QDs were first accumulated at filopodia and were eventually transported inside the cells along 
the microtubule tracks to the microtubule organizing center in the perinuclear region [82]. These 
investigators also reported that by exposing the cells to TatP-QD at 4 °C or after disrupting the 
cytoskeleton, the delivery of QDs was abrogated, suggesting that the conjugates were taken up by 
macropinocytosis. More recently, Chen et al. reported the intracellular delivery of QDs by TatP in 
human alveolar basal epithelial carcinoma cells (A549); this delivery was significantly suppressed by a 
4 °C exposure, the inhibition of ATP by NaN3/2-deoxy-D-glucose, or cholesterol depletion [83]. 
Those studies examined whether QDs were incorporated into the cells by TatP at a specific time. 
In the following section, we explain in detail our recent finding on molecular mechanisms for TatP 
to enter cells utilizing FIONA methods. 
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5.1. TatP Labeled with QDs Explores a New Phenomenon: Efficient Cell-Surface Binding Can only Be 
Achieved by Multivalent TatP  
Labeling TatP with QDs, we attempted to directly visualize the initial molecular dynamics on the 
cell membrane. This attempt included studying the moment of TatP binding on the living cell surface, 
at physiological concentrations, and we attempted to clarify the molecular mechanisms that cause the 
protein transduction. 
To visualize the interactions between TatP and the cell surface, we used TatP labeled with   
QDs [32]. The labeling of TatP with QDs is conducted by commercially available St-QDs coupled 
with biotin-TatP. As a rule, when biotin TatP is coupled with St-QD at a TatP/QD molar ratio of n:1, 
where n (number) of TatP is bound on the QD surface, the n-valent of TatP-QD is created. We first 
coupled the St-QDs with biotin-TatP at a TatP/QD molar ratio of 1:1 (designated as 1-val TatP-QDs), 
exposed them to the HeLa cells for 30 s, and observed them under a Nipkow-type confocal microscope 
at a time resolution of 400 ms/frame. The detailed results of the studies indicate that monovalent TatP 
has little to no capacity to bind to the surface of HeLa cells because each St-QD typically contains  
5–10 streptavidin molecules and 20–40 biotin-TatP molecules that can bind to each St-QD [32]. The 
cells were precultured with 30 pM monovalent TatP-QDs, and different concentrations of biotin-TatP 
were then added to the medium. We expected that the extra biotin-TatP in the medium would bind to 
the free streptavidin sites on the TatP-QDs. As expected, the binding of TatP-QD on the cells is 
induced, and the numbers of TatP-QDs that are bound to the cell surface increased proportionately 
along with the concentrations of biotin-TatP in the medium, up to 5 μM (this concentration is the 
highest that we tested so far). In contrast, the addition of unlabeled TatP to the medium at concentrations 
of up to 50 μM did not significantly enhance the ability of TatP-QDs to bind to the cell surface. These 
results suggest that the number of TatPs on the QDs could determine the capability for cell-surface 
binding. Moreover, the finding that increasing the non-biotin TatP could not increase the binding 
capability of monovalent TatP-QD indicated that direct interactions between TatP in the medium and 
TatP on QDs could not be induced (or very little); thus, the valence of TatP on the QD surface did not 
change. These results also support the earlier findings that TatP does not form an oligomer [42]. 
To test whether the increase in TatP peptides per QD enhances cellular binding, we examined the 
cell surface association of QDs with different valences of TatP utilizing single particle observations 
(Figure 3(A)). These results demonstrate that increasing the TatP valency on the QDs enhances cellular 
binding. We found that at least bivalent TatP-QD is required to support TatP-QD cell-surface binding 
on living cells at a minimum of 30 pM in concentration, and a valence of 8 is required for rapid and 
efficient cell-surface binding of TatP. Ryser et al. also obtained similar findings: they first 
demonstrated an enhancement of cellular uptake for cationic peptide polymers by multivalency [84]. 
More recently, they found that the level of conjugation of HIV-1 Tat peptides to superparamagnetic 
beads influences their cellular uptake in lymphocytes [85]. Thus, utilizing the single particle 
visualization technique, we are able to directly analyze TatP binding on the living cell surface at as low 
as 30 pM concentration, thus avoiding nonspecific uptake into cells. Moreover, by measuring the 
number of TatP-QD particles per second from the visualization data recorded at 400 ms/frame, we can 
easily measure the binding velocity of different valences on living cells.  
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Figure 3. Single TatP-QD tracking on HeLa cells. (A) Typical time course of cell binding 
for TatP-QD, with different valences, to HeLa cells. The cells were exposed to TatP-QDs 
of the indicated valence or medium, and the images were collected at 400 ms/frame; (B) Time 
course fluorescence images obtained using a dual imaging system at 200 ms/frame. 
Fluorescence images of TatP-QD525 (lower left panel) and HSPG as detected by   
F58-10E4 plus secondary Ab labeled with QD705 (lower right panel) at 20 min of TatP 
exposure; (C) Typical trajectories of 2- or 8-val TatP after 15 min of exposure, recorded at 
23 ms/frame; (D) Mean diffusion coefficient of 2- or 8-val TatP, over time up to 15 min, 
averaged for all particles in time window 1150 ms; (E) Intensity histogram of TatP-QDs at 
the indicated time and condition, fitted to four Gaussian curves. The mean of the first peak 
is equal to TatP-QD (left upper panel), defined as q1; (F) Selected frames (left) and 
trajectories of 8-val TatP-QDs from 23 ms/frame after a 15-min exposure. Arrowhead 
color corresponds to that of its trajectory; (G) 8-val TatP often exhibited alternating periods  
of apparently simple Brownian diffusion (black) and temporary immobilization (red).   
** P < 1 × 10
−7 Reproduced with permission from reference 32. Permission is required 
from copyright owner. 
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In general, multivalent interactions are characterized by the simultaneous binding of multiple 
ligands on one biological component (such as a molecule and a surface) to multiple receptors on 
another. These types of interactions occur throughout biological systems and have a number of 
characteristics that monovalent interactions do not have. Specifically, multivalent interactions can be 
collectively much stronger than the corresponding monovalent interactions; however, molecular 
mechanisms on the multivalent interactions and their biological effects are not yet fully understood. 
Utilizing single particle observations of events on plasma membranes, we can now quantitatively 
analyze the relationship between the binding velocity and multivalence in living cells. At the same 
time, we can also analyze the involvements of various cellular mechanisms by dissecting different 
steps of the TatP entry into living cells. Collectively, these results suggest the possibility that further 
improvements to single molecule microscopy might enable the measurement of the molecular binding 
constant on the living cell surface. In other words, simultaneous measurement of both the physical and 
the biological effects of multivalent interactions by single molecule microscopy may reveal the entire 
picture of the molecular mechanisms. 
5.2. Dual Imaging of TatP Labeled with Two Different-Wavelength QDs Confirms that HSPGs Are 
Essential Receptors for TatP Cell-Surface Binding 
Does TatP enter a cell through receptor-dependent or receptor-independent direct lipid bilayer 
translocation? Several recent studies have shown that cell-surface HSPGs are involved in Tat 
transduction into cells. HSPGs are composed of a core protein and ≥3 linear HS-GAG polysaccharide 
chains [50]. To answer this question, we simultaneously observed two single particles of TatP,   
TatP-QD525 and HSPGs labeled with QD705-labeled anti-HSPGs, in living cells using single 
molecule microscopy with dual imaging techniques. 
Before proceeding to dual imaging, we first studied the effect of heparin, with highly sulfated GAG, 
on the cellular binding of TatP. Single particle observation revealed that the cell-surface binding of  
8-val TatP was totally abrogated by the presence of heparin in the medium. To clarify the involvement 
of HSPGs in the cell-surface binding of TatP, we examined the effect of removing cell-surface GAGs 
with specific enzymes. We found that the treatment with HS lyase, which cleaves GAG from HSPG, 
totally abrogates 8-val TatP cell-surface binding to HeLa cells. Collectively, these results suggest that 
the GAGs of HSPGs serve as the initial receptors for TatP on the cell surface. Then, finally, 
confirming the role of HSPGs as receptors for TatP with the dual imaging techniques was required. 
After exposure, 8-val TatP-QD525 co-mobilized with HSPGs labeled with QD705-labeled anti-HSPGs 
antibodies at the cellular surface, and TatP-HSPGs were subsequently co-mobilized inside the cells 
within 45 min of 8-val TatP exposure (Figure 3(B)). Combined with the result of enzymatic removal of 
HSPGs, the dual imaging of these two single particles confirms that the cell-surface HSPGs serve as 
the initial TatP receptors, and that the TatP-HSPGs complex transports TatP inside the living cells. 
Thus, using single-molecule visualization, we finally conclude the long-debated question of the TatP 
initial cell surface binding mechanisms. Additionally, in agreement of the observation by Ruan et al. 
that TatP-QDs were initially accumulated at filopodia [82], we also found that HSPGs were abundant 
on the filopodia and lamellipodia. 
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5.3. Signaling from Multivalent TatP Facilitates the Frequent and Constitutive Recruitment of HSPGs 
to Actin-Associated Membrane Lipid Rafts 
The intensity distribution, trajectory, proportion of mobility, and the mean diffusion calculated from 
each TatP leveled QD are the key aspects of the single molecule experiment. Many unresolved 
problems can be explored by simple trajectory analysis of each QD.  
Quantitative thermodynamic description by isothermal titration calorimetry has revealed that TatP 
has a binding affinity for HS and induces crosslinking and/or aggregation of HS-TatP complexes in 
liquid medium [40]. Thus, it was reasonable for us to hypothesize that multivalent TatP induces 
crosslinking of HSPGs on the cell surface immediately after binding. To characterize the molecular 
behavior of TatP/HSPGs in the absence of crosslinking, we observed the movement of both 2-val 
TatPs, which cannot induce the crosslinking of receptors, and 8-val TatP, which can crosslink the 
HSPGs with ~7 nm spatial precision. The trajectory, the proportion of mobility, and the mean diffusion 
values for 2- and 8-val Tat were compared. The intensity distributions of the visualized spots were 
fitted to multiple Gaussian curves and were compared with the distributions of a single QD. We then 
found that cell-bound 2-val TatP consists of single QD molecules after an exposure of 2 and 15 min. In 
contrast, the trajectory, the proportion of mobility, and the mean diffusion of 8-val TatP-QDs were 
almost identical to those of 2-val TatP particles until 5 min. However, these parameters were found to 
drop substantially over time until 15 min, indicating that the compartmentalization of the mobility of 
TatP-QDs occurs on the cell surface (Figure 3(C,D)). The intensity distributions of the cell-bound  
8-val TatP particles were found to be gradually increased, suggesting that they consisted of more than 
two QDs (designated here as spots>2 QDs) (Figure 3(E,F)). We found that, after partial actin 
depolymerization (by latrunculin-B) or partial cholesterol depletion (by methyl-β-cyclodextrin, MBC), 
the reduction of the diffusion of the 8-val TatP and the appearance of the spots>2, the QDs almost 
completely disappeared. Collectively, these results indicate that the reduction in the movement of the 
8-val TatP/HSPGs and the increase in the number of spots>2 QDs were linked to the actin filaments 
and the cholesterol-rich domains in the membrane, known as lipid rafts or membrane microdomains.  
When we analyzed the mobility of 2-val and 8-val TatP-QD for longer periods with 23 ms/frame, 
after 15 min of exposure, we found that only 8-val TatP particles often exhibited very abnormal 
movements, namely, 8-val TatP undergoes alternating periods of simple Brownian diffusion and 
temporary immobilization in its trajectories (Figure 3(G)). These temporary pauses persisted for nearly 
half of the total observation time, and thus, the temporary immobilization-to-diffusion ratio was 1:2. 
This mobility is, surprisingly, almost identical to that of colloidal gold-induced crosslinking of CD59, 
and the temporary immobilization is designated as a stimulation-induced temporary arrest of lateral 
diffusion (STALL) [80,81]. By performing detailed experiments, Suzuki et al. revealed the molecular 
mechanisms for STALL in the crosslinking of CD59. The crosslinking of CD59 exhibited a frequent 
but transient recruitment in the lipid raft domain via both protein-protein and lipid-lipid (raft) 
contributions, and CD59 underwent alternating periods of actin-dependent STALL. At the lipid raft, 
the signaling molecules also formed into CD59 clusters and appeared to activate an unknown protein 
thereafter. CD59 clusters are indirectly associated with the actin cytoskeleton which has lipid 
membrane microdomains via protein-protein interactions; these are likely to have a key function in 
converting extracellular CD59 signals to the intracellular Ca
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finding to our results, 8-val TatP-QD/HSPGs were frequently recruited to lipid microdomains and 
activated intracellular signaling molecules using some unknown mechanisms, which might cause 
frequent but transient recruitment to the actin cytoskeleton with lipid membrane microdomains. As a 
result, 8-val TatP-QD/HSPGs are frequently recruited and are stopped at the lipid raft, and thus appear 
to link to induce spots>2 QDs. Indeed, the STALL-like mobility of 8-val TatP was also inhibited by 
both partial depolymerization of the actin filaments and partial cholesterol depletion, indicating that 
this action was induced by mechanisms similar to STALL. 
5.4. Multivalent TatP Activates Rac1 to Slow Molecular Movement and Induce Internalization  
through Macropinocytosis 
Full-length Tat protein exposure activates Rac1, a GTP-binding protein that regulates membrane 
actin polymerization [57]. We hypothesized that the crosslinking of HSPGs by 8-val TatP causes the 
recruitment and activation of Rac1 adjacent to the lipid rafts and the membrane actin near the raft domains, 
and regulates membrane actin polymerization, resulting in reducing the diffusion of TatP-QD/HSPG 
and also activating some mechanisms for taking up TatP-QD/HSPG from the cell surface. 
We first measured the amplitude and the time course of Rac1 activation in the cells exposed to 2-val 
and 8-val TatP and found that 8-val TatP-QDs activates Rac1 within 7 min of exposure, continuing 
until 15 min of exposure. In contrast, the induction of Rac1 activation was marginal in cells that were 
exposed to 2-val TatP (Figure 4(A)). Furthermore, Rac1 was found to be clustered with TatP-coated 
beads and not with uncoated beads, confirming that the crosslinking of HSPGs by 8-val TatP recruited 
Rac1 to the membrane. We also studied the mobility of individual 8-val QDs in cells that were   
pre-exposed to NCS23766, a Rac1 inhibitor (Figure 4(B)). We found that the reductions of average 
diffusion and the induction of STALL-like events were suppressed by the Rac1 inhibitor. The gradual 
increase in the number of the spots>2 QDs over time was also found to be significantly suppressed by 
the inhibitor.  
Figure 4. Activation of Rac1 by 8-val-TatP exposure linked to slowerig diffusion and TatP 
internalization by macropinocytosis.  (A) levels of activated Rac1 after 8-val or   
2-val TatP-QD exposure. HeLa cells, Lysates were harvested, and Pak1 pulldown was 
performed. Samples from pulldowns were loaded and blotted with anti-Rac1. The numbers 
indicate the level of Rac1 activation; (B) mean diffusion coefficient of 8-val TatP in the 
presence and absence of LatB, Rac1 inhibitor (RacI), and MBC. Bars, S.E. ** p < 1 × 10
−15 
as calculated by Student’s t test; (C) effects of cytochalasin D (CyD), MBC, amiloride 
(AMI), Rac1 inhibitor (RacI), and Dynasore (Dyn). Bars, S.D.  
 Sensors 2012, 12  563 
 
 
Figure 4. Cont. 
 
 
These results indicate that there was crosslinkage of the HSPGs by TatP, activating Rac1 and causing 
membrane actin polymerization. We then examined whether Rac1 activation by multivalent TatP is linked 
to the internalization of TatP/HSPGs. We found that the internalization of 8-val TatP is suppressed by 
inhibiting actin polymerization (cytochalasin D) and Na+/H+ exchange, which are required for 
macropinocytosis (amiloride), and is also suppressed by changing cholesterol levels with MBC, as 
reported previously. The inhibitor for dynamin (Dynasore), a GTPase that is responsible for most of the 
endocytotic pathways, had no effect (Figure 4(C)). From these data, we can confidently assume that the 
exposure of cells to 8-val TatP induces the internalization of TatP through macropinocytosis. 
 
Figure 5. A schematic presentation of the events in the plasma membrane exposed to 2-val 
and 8-val TatP.  HSPG exists as a monomer; 8-val TatP clusters with several HSPGs, 
leading to recruitment of Rac1 to lipid rafts, which triggers membrane reorganization of 
actin filaments and/or actin-dependent domains and induces the temporary immobilization 
and clustering of 8-val TatP/HSPGs. Rac1 activation induces TatP/HSPG internalization 
through macropinocytosis. The major sequential rate-limiting steps of TatP intracellular 
delivery are also described. Numbers of the initial binding velocity (BV) shown here are in 
arbitrary units. The right column indicates the representative rate-limiting factors. 
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By the introduction of single-QD tracking with FIONA, we can now directly observe the molecular 
events of TatP in physiological concentrations; therefore, we are able to directly prove that “TatP 
induces the signals and changing molecular motion of the TatP/HSPGs and is incorporated into cells 
through macropinocytosis”. These visualization techniques can also be used to directly prove the 
location of the rate-limiting step for protein transduction. Therefore, the direct identification of a   
rate-limiting step of the PTD entry now can be possible, which is crucial to improving the efficiency of 
PTD based on knowledge gained from the experiments, rather than relying on observations of the 
biological output (Figure 5). Thus, single QD visualization of PTDs will greatly contribute to 
improving observations on their transduction efficacy. Moreover, this technology is expectedly to 
contribute to the improvement of intracellular labeling technology with QD. 
6. Problems with QD and Challenges for the Future 
The superior photoluminescence properties of QDs make it possible to observe the mobility of TatP 
at the molecular level, at physiological concentrations. Despite these superior characteristics, it was 
also revealed that there are several serious drawbacks in the use of QDs. We will discuss here briefly 
the photoluminescent problems, the functionalization and hydrodynamic size of the QD, and possible 
methods for the solution to these problems as well.  
6.1. Blinking of QDs 
Blinking of QDs is a phenomenon in which photoluminescence turns “on” and “off” intermittently, 
even under continuous photoexcitation [28,61,86]. This phenomenon is an intrinsic limitation to the 
advancement of QD technology toward single-molecule biophysical and biochemical investigations. 
Blinking is quite troublesome, especially for tracking a molecule for longer periods because 
trajectories of labeled molecules must be reconstructed from a transiently disappearing signal. Thus, it 
is almost impossible to track down a single QD for longer periods regardless of its extremely 
photoresistant nature. It is important to understand the underlying fundamental mechanisms for 
blinking, and they are currently being extensively investigated at both the theoretical and practical 
levels [87–90]. Although the details are still unclear, a consensus has emerged that photoluminescence 
blinking is fundamentally caused by intermittent Auger ionization, which results in the formation of 
positively charged QDs. Because of strong Coulombic interactions, successive photoactivation of a 
charged QD results in nonradiative carrier recombination, inducing long-lived ‘off’ states in the 
photoluminescence intensity. Various approaches have been investigated to address and suppress the 
blinking photoluminescence of QDs, including the effects of novel metal nanoparticles/surfaces, 
temperature, a shell thickness of higher band gap materials, electron transfer to and from inorganic 
NPs and organic molecules, capping by thiols and polymers, oxygen depletion, modiﬁed synthesis, and 
excitation energy and intensity [29]. Among the relevant efforts, Wang et al. recently accomplished the 
synthesis of a completely nonblinking ternary core/shell CdZnSe/ZnSe QD by circularly alloying 
CdZnSe into ZnSe [91]. It is extremely important to invent innovative methods for suppressing the 
blinking of single QDs. However, researchers have now proceeded despite this difficulty, for the sake 
of isolating meaningful information from the currently available QDs, which undergo blinking. They 
attempt to overcome blinking with the serial tracking of QDs until they blink off; in other words, they Sensors 2012, 12  565 
 
 
are observed for a short period at different time intervals and then are reconstituted into a continuous 
series of single TatP-QD mobility measurements from these data. Another option for overcoming the 
blinking issue is utilizing aggregated QDs [67]. If QDs aggregate, the mean off-state time is shortened 
because of overlapping blinking particles. Whenever one QD is in the on-state, the entire aggregate 
will appear to be “on”. It might not be worth the effort to explore the influence of the hydrodynamic 
effects on aggregated QDs in order to understand the dynamics of the labeled molecules. Nevertheless, 
the tracking of human epidermal factor 2 receptors inside cells labeled with the aggregated QDs can 
readily identify the QD transportation by myosin VI, consisting of 29- and 15-nm steps, indicating that 
successful observation of myosin VI hand-over-hand movement is achieved by this method [67,71]. If 
the tracking down of single molecules that are labeled with nonblinking QDs can be possible in the 
future, then it would not be surprising to identify a novel behavior of the molecules that cannot be 
expected from the reconstructed data of shorter periods. Similarly, tracking of the intracellular TatP 
behavior for longer periods with nonblinking QDs is a potential application for identification of   
rate-limiting steps of PTD to enhance their transduction efficacy. 
6.2. Functionalization and the Hydrodynamic Size of QDs  
Synthesized high-quality core and core/shell QDs are usually covered by a layer of hydrophobic 
molecules [29,64,86]. Thus, conversion of QDs from an organic to an aqueous phase has become 
necessary for biocompatibility. For biological applications of QDs, the surface cap should have intact 
or improved optical properties, mono-dispersion in aqueous phase, functional groups for bioconjugation, 
and protection against chemical/biochemical/physical damage and dissolution of toxic materials. In 
this regard, sequential introduction of a primary shell from a higher band-gap semiconductor, a silica 
shell and/or a polymer shell, a PEG layer, and functional groups for bioconjugate reactions are 
preferable. However, the hydrodynamic size of the QDs should be controlled for a better compromise 
among the sizes of the QD, the binding/labeling efficiency, and the functioning of targets after labeling. 
Functionalization is now typically achieved by conjugating reactive biomolecules (e.g., enzymes, 
antibodies, nucleic acids) and polyethylene glycol (PEG), which is often necessary to minimize 
nonspecific interactions of the QD with biological material. Nonspeciﬁc binding is hostile for the  
high-contrast imaging of cells, as well as for the fateful observation of the molecular mobility of the 
labeled molecules. Owing to the functionalization of the surface with PEG, commercially available 
QDs show almost negligible levels of nonspecific binding. However, their hydrodynamic size is   
~20–40 nm, which is larger than the optimal size for tracking labeling molecules on the cellular 
surface. For example, when we track down the TatP-QD molecules on the ventral side, the QD could 
not readily enter the space in-between the ventral membrane and the cover slip, and eventually became 
stuck at the marginal area of the ventral surface. Thus, a much smaller size that minimizes nonspecific 
interactions of QDs should be invented. For this endeavor, researchers are now focused on inventing 
various methods for functionalizing QDs as well as synthesizing new core/shell materials for QDs. 
7. Conclusions 
By tracking, observing, and measuring the motility of the single TatP-QD using FIONA methods, 
we can identify critical limiting steps for TatP intracellular delivery. This method also provides Sensors 2012, 12  566 
 
 
information on the cell surface binding velocity of TatP-HSPGs on a living cell surface. Most 
importantly, these simple techniques can easily provide direct information regarding TatP cell surface 
binding mechanisms as well as their entry mechanisms, which have been debated for more than a 
decade. Moreover, our method here for direct identification of rate-limiting steps of PTD entry with 
SQT should dramatically improve methods for enhancing the transduction efficiency. Although more 
effort is needed to synthesize idealistically functionalized QDs without blinking, FIONA with labeled 
QDs should prove to be a valuable tool to interpret the rules governing the dynamic architecture of 
living cells, and will possibly reshape some important conceptual ideas in cell biology.  
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